Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Pfizer Inc

Market Cap 15TCr 13TCr 12TCr 11TCr 21TCr 14,19900Cr 21TCr 1,40400Cr 55TCr 6,91100Cr 56TCr 55TCr 23,93000Cr P/E Ratio 2026 *
12.3x
P/E Ratio 2027 * 13x
Enterprise Value 20TCr 17TCr 16TCr 15TCr 28TCr 18,78800Cr 28TCr 1,85800Cr 72TCr 9,14500Cr 74TCr 73TCr 31,66300Cr EV / Sales 2026 *
3.2x
EV / Sales 2027 * 3.23x
Free-Float
59.05%
Yield 2026 *
6.68%
Yield 2027 * 6.66%
Manager TitleAgeSince
Chief Executive Officer 64 01/01/2019
Director of Finance/CFO 61 02/05/2022
Chief Tech/Sci/R&D Officer - 01/01/2007
Director TitleAgeSince
Director/Board Member 68 01/09/2007
Director/Board Member 62 27/09/2013
Chairman 64 01/01/2020
Change 5-day change 1-year change 3-year change Capi.($)
-2.41%+0.14%+39.53%+154.43% 1,01000Cr
+1.07%+3.48%+53.75%+50.64% 58TCr
+1.32%+0.22%+18.35%+65.35% 40TCr
+0.77%0.00%+19.99%+16.80% 33TCr
-1.42%-1.44%+45.50%+8.37% 29TCr
-0.85%-2.86%+22.05%+13.80% 28TCr
+0.44%+3.48%+24.48%+34.39% 28TCr
+1.66%+1.20%-44.67%-47.49% 20TCr
+0.32%+1.61%+19.48%+63.42% 19TCr
Average -0.28%+0.99%+22.05%+39.97% 39.63TCr
Weighted average by Cap. -0.80%+1.00%+29.84%+66.16%

Financials

2026 *2027 *
Net sales 6.17TCr 5.33TCr 4.91TCr 4.6TCr 8.61TCr 5,86400Cr 8.75TCr 58TCr 23TCr 2,85400Cr 23TCr 23TCr 9,88200Cr 5.93TCr 5.12TCr 4.72TCr 4.42TCr 8.28TCr 5,63900Cr 8.41TCr 56TCr 22TCr 2,74500Cr 22TCr 22TCr 9,50300Cr
Net income 1.11TCr 956.12Cr 881.06Cr 824.72Cr 1.55TCr 1,05200Cr 1.57TCr 10TCr 4.06TCr 51TCr 4.15TCr 4.07TCr 1,77300Cr 1.1TCr 946.65Cr 872.34Cr 816.55Cr 1.53TCr 1,04200Cr 1.55TCr 10TCr 4.02TCr 51TCr 4.11TCr 4.03TCr 1,75600Cr
Net Debt 4.83TCr 4.17TCr 3.84TCr 3.6TCr 6.74TCr 4,58900Cr 6.84TCr 45TCr 18TCr 2,23400Cr 18TCr 18TCr 7,73300Cr 4.21TCr 3.63TCr 3.35TCr 3.13TCr 5.87TCr 3,99900Cr 5.97TCr 40TCr 15TCr 1,94700Cr 16TCr 15TCr 6,74000Cr
Logo Pfizer Inc
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (47.4%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (26.2%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (24.5%); - other (1.9%). The United States accounts for 60.8% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!